Published in Am J Obstet Gynecol on April 01, 1991
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol (2008) 1.56
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer (1995) 1.44
Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer (2002) 1.27
Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patients with resectable hepatocellular carcinoma. Ann Surg (2000) 1.22
Serum interleukin-6 and -10 levels in patients with gastric cancer. Gastric Cancer (2009) 1.21
Phase II trial of single agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash. Gynecol Oncol (2009) 1.14
Chemotherapeutic drugs and human tumor cells cytokine network. Int J Cancer (2008) 1.11
Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol (2014) 1.08
Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol (2006) 1.07
IL-6/IL-6R as a potential key signaling pathway in prostate cancer development. World J Clin Oncol (2011) 1.07
Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. J Proteome Res (2010) 1.07
Biobehavioral influences on cancer progression. Immunol Allergy Clin North Am (2011) 1.04
Genomic and proteomic biomarkers for cancer: a multitude of opportunities. Biochim Biophys Acta (2009) 1.03
Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC). J Transl Med (2004) 1.02
IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity. Br J Cancer (2000) 0.98
Beyond CA125: the coming of age of ovarian cancer biomarkers. Are we there yet? Biomark Med (2009) 0.95
IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells. J Biol Chem (2011) 0.95
The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br J Cancer (2004) 0.91
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease. J Transl Med (2006) 0.91
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer. Cancer Chemother Pharmacol (2013) 0.90
Interleukin-6 and acute-phase proteins in head and neck cancer. Eur Arch Otorhinolaryngol (1995) 0.89
Common polymorphism in interleukin 6 influences survival of women with ovarian and peritoneal carcinoma. Gynecol Oncol (2006) 0.85
Plasma immune analytes in patients with epithelial ovarian cancer. Cytokine (2015) 0.85
The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan. J Clin Immunol (2009) 0.83
Expression of VEGF, EGFR, and IL-6 in gastric adenomas and adenocarcinomas by endoscopic submucosal dissection. Dig Dis Sci (2009) 0.83
Interleukin-6 and leptin as markers of energy metabolic changes in advanced ovarian cancer patients. J Cell Mol Med (2008) 0.81
Interleukin-6 (IL-6) production in carcinoma of the cervix. Arch Gynecol Obstet (1996) 0.81
Association of interleukin-6 genetic polymorphisms with risk of OSCC in Indian population. Meta Gene (2015) 0.79
The role of interleukin-6 in malignant mesothelioma. Transl Lung Cancer Res (2015) 0.78
Ovarian epithelial-stromal interactions: role of interleukins 1 and 6. Obstet Gynecol Int (2011) 0.78
Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women. J Transl Med (2012) 0.77
Interleukin-6 from Ovarian Mesenchymal Stem Cells Promotes Proliferation, Sphere and Colony Formation and Tumorigenesis of an Ovarian Cancer Cell Line SKOV3. J Cancer (2016) 0.75
Prognostic biomarkers in ovarian cancer. Cancer Biomark (2011) 0.75
Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring. J Ovarian Res (2015) 0.75
Atmospheric brown clouds: impacts on South Asian climate and hydrological cycle. Proc Natl Acad Sci U S A (2005) 8.06
Tuberculosis in Britain today. BMJ (1993) 6.17
"Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. BMJ (1991) 4.56
RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol (2001) 3.79
Screening migrants at risk of tuberculosis. BMJ (1993) 3.34
Factors that determine false recall: a multiple regression analysis. Psychon Bull Rev (2001) 3.08
Socioeconomic deprivation and notification rates for tuberculosis in London during 1982-91. BMJ (1995) 3.06
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
Outbreak of isoniazid resistant tuberculosis in north London. Thorax (2004) 2.82
Evidence for genetic exchange and recombination of Rhizobium symbiotic plasmids in a soil population. Appl Environ Microbiol (1987) 2.76
DNA sequence of Rhizobium trifolii nodulation genes reveals a reiterated and potentially regulatory sequence preceding nodABC and nodFE. Nucleic Acids Res (1986) 2.68
Genetic and molecular characterization of the Pseudomonas plasmid pVS1. Plasmid (1984) 2.44
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
Chromosome mapping in Pseudomonas aeruginosa PAT. J Bacteriol (1978) 2.38
Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J Immunol (1989) 2.27
Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest (2000) 2.21
Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur J Epidemiol (2003) 2.20
BCG immunisation in England and Wales: a survey of policy and practice in schoolchildren and neonates. BMJ (1992) 2.13
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol (1987) 2.11
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis (2012) 2.00
Prevalence, morbidity and service need among South Asian and white adults with intellectual disability in Leicestershire, UK. J Intellect Disabil Res (2002) 1.98
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science (1992) 1.98
Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis (2003) 1.95
Tuberculosis among the homeless at a temporary shelter in London: report of a chest x ray screening programme. J Epidemiol Community Health (1995) 1.91
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax (2007) 1.86
Suppressor mutations in Pseudomonas aeruginosa. J Bacteriol (1976) 1.81
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Solvent encephalopathy. Br Med J (Clin Res Ed) (1981) 1.66
The effects of sample selection bias on racial differences in child abuse reporting. Child Abuse Negl (1998) 1.65
Mycobacterium bovis in England and Wales: past, present and future. Epidemiol Infect (1992) 1.64
Abuse of solvents "for kicks". A review of 50 cases. Lancet (1977) 1.62
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
Notification of tuberculosis: an updated code of practice for England and Wales. J R Coll Physicians Lond (1997) 1.52
The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis (2009) 1.50
Evaluating functional MRI procedures for assessing hemispheric language dominance in neurosurgical patients. Neuroradiology (2005) 1.49
Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res (1990) 1.42
Depressive illness in general practice: a pilot study. Health Bull (Edinb) (1981) 1.40
Influenza types and patient population. Lancet (1995) 1.37
Antibody-secreting cell precursor frequencies among the sheep-erythrocyte-binding cells after immunization. Scand J Immunol (1983) 1.37
Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991. Commun Dis Rep CDR Rev (1993) 1.36
Construction of recombination-deficient strains of Pseudomonas aeruginosa. Mol Gen Genet (1983) 1.33
Genetic Diversity among Rhizobium leguminosarum bv. Trifolii Strains Revealed by Allozyme and Restriction Fragment Length Polymorphism Analyses. Appl Environ Microbiol (1991) 1.33
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill (2013) 1.32
Expression of biosynthetic genes from Pseudomonas aeruginosa and Escherichia coli in the heterologous host. Mol Gen Genet (1986) 1.32
Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis. Health Technol Assess (2013) 1.31
Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol (1998) 1.31
SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.28
MR imaging of tophaceous gout. AJR Am J Roentgenol (1997) 1.27
Appropriateness of thresholds currently used to describe influenza activity in England. Commun Dis Public Health (2003) 1.27
Linkage map of Pseudomonas aeruginosa PAT. J Bacteriol (1978) 1.25
TB in Leicester: out of control, or just one of those things? BMJ (2001) 1.25
Opportunist mycobacteria in England and Wales: 1982 to 1994. Commun Dis Rep CDR Rev (1996) 1.24
Influenza surveillance in England and Wales: October 1999 to May 2000. Commun Dis Public Health (2000) 1.24
Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Clin Immunol (1999) 1.24
Are healthcare workers in England and Wales at increased risk of tuberculosis? BMJ (1996) 1.23
Pandemic (H1N1) 2009 influenza in the UK: clinical and epidemiological findings from the first few hundred (FF100) cases. Epidemiol Infect (2010) 1.23
Comparative mapping identifies the fusion point of an ancient mammalian X-autosomal rearrangement. Genomics (1996) 1.23
The development of AIDS-associated Burkitt's/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6. Clin Immunol (1999) 1.23
Changes in demand for initial medical care in general practice and hospital accident and emergency departments. Br Med J (1979) 1.21
Five-year winter chemoprophylaxis for chronic bronchitis. Br Med J (1969) 1.20
A decade of change: tuberculosis in England and Wales 1988-98. Arch Dis Child (2003) 1.20
N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease. J Biol Chem (2001) 1.20
Tuberculosis screening in migrants in selected European countries shows wide disparities. Eur Respir J (2006) 1.20
Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database. Epidemiol Infect (1995) 1.19
Database study of antibiotic resistant tuberculosis in the United Kingdom, 1994-6. BMJ (1999) 1.19
Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist. Arch Int Pharmacodyn Ther (1983) 1.17
Risk of lymphoma subtypes after solid organ transplantation in the United States. Br J Cancer (2013) 1.17
Molecular characterization of the nodulation gene, nodT, from two biovars of Rhizobium leguminosarum. Mol Microbiol (1990) 1.15
Geographical and social variations in mortality due to childhood accidents in England and Wales 1975-1984. Public Health (1990) 1.13
Can calls to NHS Direct be used for syndromic surveillance? Commun Dis Public Health (2001) 1.13
Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea. Acta Neurol Scand (2003) 1.13
Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C. Clin Pharmacol Ther (2001) 1.13
An estimate of the contribution of HIV infection to the recent rise in tuberculosis in England and Wales. Thorax (2002) 1.12
The origin and loss of the ubiquitin activating enzyme gene on the mammalian Y chromosome. Hum Mol Genet (1998) 1.12
Molecular characterisation and expression of a wound-inducible cDNA encoding a novel cinnamyl-alcohol dehydrogenase enzyme in lucerne (Medicago sativa L.) Plant Mol Biol (1999) 1.12
Record-linkage and capture-recapture analysis to estimate the incidence and completeness of reporting of tuberculosis in England 1999-2002. Epidemiol Infect (2008) 1.10
Mammalian sex chromosomes: evolution of organization and function. Chromosoma (1991) 1.09
Body mass index in adults with intellectual disability: distribution, associations and service implications: a population-based prevalence study. J Intellect Disabil Res (2008) 1.09
Molecular epidemiology of tuberculosis in England, 1998. Int J Tuberc Lung Dis (2009) 1.09
A statewide outbreak of cryptosporidiosis in New South Wales associated with swimming at public pools. Epidemiol Infect (2001) 1.09
Slaughter of animals without pre-stunning. Vet Rec (1994) 1.08
Socioeconomic status, ethnicity, and environmental tobacco exposure among non-smoking females. Nicotine Tob Res (2000) 1.08
Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma. Blood (1995) 1.08
In vitro regulation of B cell differentiation by interleukin-6 and soluble CD23 in systemic lupus erythematosus B cell subpopulations and antigen-induced normal B cells. Arthritis Rheum (1991) 1.08
Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers. Cytokine (1992) 1.06
Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol (1996) 1.05
Two outbreaks of Legionnaires' disease in Bolton Health District. Epidemiol Infect (1990) 1.05
Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997. Eur J Epidemiol (1999) 1.05
Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis (2007) 1.04
Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy. Cancer Res (1999) 1.04
Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression. Obstet Gynecol (2000) 1.03
The molecular epidemiology of tuberculosis in inner London. Epidemiol Infect (2002) 1.03
Tuberculosis in England and Wales 1982-1993: notifications exceeded predictions. Commun Dis Rep CDR Rev (1995) 1.02